Impaired host defense mechanisms following surgical stress such as burn, major surgery and polytrauma are considered important for the development of infectious complications and sepsis. We tested whether interferon (IFN) gamma can improve monocytic and lymphocytic functions and can reduce deaths related to sepsis. In order to restore their antimicrobial defense capacity, recombinant human IFN-gamma, 100 μg, was administered intravenously once daily to six immunoparalyzed patients. Informed consent was obtained from patients in all cases, and the study received local hospital ethical committee approval. Intracytoplasmic Th1 and Th2 cytokine production in isolated peripheral blood mononuclear cells was assessed by flow cytometry following *in vitro*activation by phorbol myristate acetate plus ionomycin. Monocytic human leukocyte antigen-DR (HLA-DR) expression was also measured. Immunoparalysis was defined as a decreased level of HLA-DR expression of monocytes \<30% or a decreased level of Th1 \<10%. IFN-gamma applied to immunoparalytic patients with low monocytic HLA-DR expression restored the deficient HLA-DR expression and *in vitro*Th1 cytokine production completely within 3 days. Recovery from immunoparalysis resulted in clearance of sepsis in four of six patients. IFN-gamma administration in septic patients accompanied with immunoparalysis is a new therapeutic strategy.

  Age (years)   HLA-DR (%) before IFN   HLA-DR (%) 3 days after IFN   Th1 (%) before IFN   Duration of IFN treatment (days)   Outcome   Diagnosis
  ------------- ----------------------- ----------------------------- -------------------- ---------------------------------- --------- -------------
  45            27.9                    43                            4                    12                                 Dead      Flame burn
  72            7.5                     19                            3                    12                                 Dead      Ileus
  30            8                       21                            2.2                  3                                  Dead      Pneumonia
  37            25.1                    33                            9                    12                                 Live      Peritonitis
  56            29.7                    74                            9                    7                                  Live      Peritonitis
  75            27                      56                            8.9                  5                                  Live      Pneumonia
